Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Agfa Gevaert N.V.

Start price
Target price
Perf. (%)
€4.44
26.08.21
€5.50
26.08.22
-25.11%
27.08.22

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€47.19
26.08.21
-
26.08.22
5.16%
17.11.21

buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€100.15
26.08.21
-
26.08.22
-2.84%
26.08.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€13.84
25.08.21
-
25.08.22
-32.23%
26.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.20
24.08.21
-
24.08.22
-24.81%
25.08.21

Probably not worthwhile Investment
buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€629.00
24.08.21
-
24.08.22
-38.00%
24.08.22

buy
Merck KGaA

Start price
Target price
Perf. (%)
€203.40
24.08.21
-
24.08.22
-13.03%
24.08.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€126.20
24.08.21
-
24.08.22
-67.27%
24.08.22

buy
Hexo Corp.

Start price
Target price
Perf. (%)
€31.22
23.08.21
-
23.08.22
-18.39%
14.09.21

Could be worthwhile Investment >10% per year
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€20.42
23.08.21
-
23.08.22
23.56%
14.09.21

Could be very worthwhile Investment >20% year
Innovative
Some uniques
Future proof or reliable business model
buy
Endo International

Start price
Target price
Perf. (%)
€2.07
23.08.21
-
23.08.22
11.85%
14.09.21

Capable Management
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€22.67
23.08.21
€28.00
23.08.22
-0.88%
04.09.21

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
buy
CASI Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€12.50
23.08.21
€10.00
23.08.22
7.20%
04.09.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Dependend from some customers or products
Evotec SE

Start price
Target price
Perf. (%)
€42.98
23.08.21
-
23.08.22
-7.56%
11.10.21

Risky Investment
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€299.10
21.08.21
€325.00
21.08.22
-10.60%
22.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.58
21.08.21
€220.00
21.08.22
-13.54%
08.01.22

Revenue growth >5% per year expected
Undervalued
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€123.30
17.08.21
-
17.08.22
-27.01%
12.01.22

buy
ESSA Pharma Inc

Start price
Target price
Perf. (%)
€6.85
16.08.21
-
16.08.22
-0.73%
22.08.21

Risky Investment
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€15.31
16.08.21
-
16.08.22
-2.09%
22.08.21

Risky Investment
buy
Bayer AG

Start price
Target price
Perf. (%)
€47.80
14.08.21
-
14.08.22
0.36%
04.01.22

Higher risks for its business
Increased challenges to pay loans and raise capital
buy
Coloplast A/S B

Start price
Target price
Perf. (%)
€151.65
13.08.21
€165.00
13.08.22
4.21%
30.12.21

Future proof or reliable business model
Known brand
Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€38.22
13.08.21
-
13.08.22
-3.95%
22.08.21

Risky Investment
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€52.08
13.08.21
€20.00
13.08.22
-65.13%
08.01.22

Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€12.20
10.08.21
-
10.08.22
-13.93%
13.08.21

Probably not worthwhile Investment
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€23.17
10.08.21
-
10.08.22
-11.87%
23.08.21

Could be very worthwhile Investment >20% year
Innovative
Some uniques
Future proof or reliable business model